Aradigm (ARDM.OB) Developing Inhalable Drugs
As medical technology moves further and further away from the tools of the past, companies are developing new technologies to make life easier for people suffering from diseases that once led to extreme discomfort, or at least a severe crippling of one's lifestyle. One of these companies, Aradigm Corporation (OTCBB: ARDM) is working on an interesting branch of drug delivery that few other companies have really paid any attention to - inhalants."We are developing treatment for severe infections associated with chronic respiratory diseases," Igor Gonda, CEO of Aradigm, recently told MN1. "So we're developing an antibody treatment using an old…